RT Journal Article
SR Electronic
T1 Barriers to accessing mother, new-born and child health services in urban Gambia during COVID-19: An interview-based qualitative study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.10.06.22280770
DO 10.1101/2022.10.06.22280770
A1 Bah, Abdourahman
A1 Russo, Giuliano
YR 2022
UL http://medrxiv.org/content/early/2022/10/07/2022.10.06.22280770.abstract
AB Introduction Evidence is being consolidated that shows that the utilisation of mother, newborn, and child health (MNCH) services has declined in low-income countries (LICs) during the COVID-19 pandemic. Very little is known about the effects of the pandemic on MNCH service utilisation in the Gambia. We set out to explore the COVID-19-related factors affecting the utilisation of antenatal and immunisation services in the Gambia.Methods A qualitative methodology was used to explore patients’ and providers’ experiences of MNCH services during the pandemic in two Local Government Areas (LGAs) in the Gambia. Thirty-one study participants were recruited from four health facilities, applying a theory-driven sampling framework, including health workers as well as female patients. Qualitative evidence was collected through theory-driven semi-structured interviews, and was recorded, translated into English, transcribed, and analysed thematically, applying a social-ecological framework.Results In our interviews, we identified five main themes, ranging from individual factors to interpersonal, community, institutional and policy factors. Individual factors revolved around patients’ fear of being infected in the facilities, and of being quarantined, and their anxiety about passing on infections to family members. Interpersonal factors involved the reluctance of partners and family members, as well as perceived negligence and disrespect by health workers. Community factors included misinformation within the community and mistrust of vaccines. Institutional factors included the shortage of health workers, closures of health facilities, and the lack of personal protective equipment (PPEs) and essential medicines. Finally, policy factors revolved around the consequences of COVID-19 prevention measures, particularly the shortage of transport options and mandatory wearing of face masks.Conclusions Our findings suggest that patients’ fears of contagion, perceptions of poor treatment in the health system, and a general anxiety around the imposing of prevention measures, undermined the uptake of MNCH services. In future emergencies, the government in the Gambia, and governments in other LICs, will need to consider the unintended consequences of epidemic control measures on the uptake of MNCH services.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Scientific and ethical approvals were obtained from the Medical Research Council Unit of the Gambia (MRCG) Scientific Coordinating Committee and the Gambia Government/MRCG Joint Ethics Committee, respectively. Official permission letters were also obtained from the Director of Health Services at the Ministry of Health and from the administrative offices of all four health facilities. After explaining the purpose of the study, written consent was obtained from all study participants. To ensure confidentiality and anonymity, the interview data was anonymised.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableThe datasets collected and analyzed for the current study is available from the corresponding author and can be obtained upon reasonable request.